21026 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Hydrolases (3)
Sub-classes:RECOMBINANT APYRASE PROTEIN FOR USE IN THE TREATMENT OF AN ISCHEMIC EVENT AT A DOSE OF 40-240 MG
#2MEANS AND METHODS FOR CLEAVAGE OF ZEARALENONE
#3METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV
#4NEW SYNTHETIC DRUGS FOR TREATING ALZHEIMER'S DISEASE
#5Nanoparticles for Enhancing Mitochondrial Networks
#6CD39 AND CD73 FOR THE THERAPY OF HEMORRHAGIC SHOCK
#7TARGETING CREB-HEPARAN SULFATE-FGF PATHWAY FOR CANCER TREATMENT
#8CNS DELIVERY OF THERAPEUTIC AGENTS
#9Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders
#10Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#11HOMOLOGY INDEPENDENT TARGETED INTEGRATION FOR GENE EDITING
#12FUNCTIONAL NUCLEIC ACID MOLECULES
#13GENE THERAPY FOR THE TREATMENT OF HT1
#14TREATMENT OF ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY
#15METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#16METHODS FOR TREATING INHERITED METABOLIC DISORDERS
#17EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION
#18GENE THERAPY FOR THE TREATMENT OF WILSON'S DISEASE
#19THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM
#20CODON-OPTIMIZED REDUCED-SIZE ATP7A CDNA AND USES FOR TREATMENT OF COPPER TRANSPORT DISORDERS
#21METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
#22CIRCULAR RNA VACCINES AND METHODS OF USE THEREOF
#23LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF
#24USE OF LYSIN TO RESTORE/AUGMENT ANTIBACTERIAL ACTIVITY IN THE PRESENCE OF PULMONARY SURFACTANT OF ANTIBIOTICS INHIBITED THEREBY
#25TREATMENT OF NUDT2 MUTATION
#26GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA
#27COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#28PHARMACEUTICAL COMPOSITIONS CONTAINING ADENO-ASSOCIATED VIRAL VECTOR
#29USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY
#30METHODS AND COMPOSITIONS FOR TREATING OCULAR DISEASES AND DISORDERS
#31METHODS FOR INCREASING RED BLOOD CELL HALF-LIFE AND ASSOCIATED TREATMENT OF ANEMIA
#32ISOLATED OR ARTIFICIAL NUCLEOTIDE SEQUENCES FOR USE IN NEURODEGENERATIVE DISEASES
#33COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION
#34FUSION PROTEINS COMPRISING SULFOGLUCOSAMINE SULFOHYDROLASE ENZYMES AND METHODS THEREOF
#35Chimeric endolysin polypeptide
#36PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES
#37Self-complementary AAV vectors carrying dominant negative RhoA and methods of use to treat ocular diseases
#38ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY
#39FUSION PROTEIN, AND PREPARATION METHOD AND USE THEREOF
#40Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto
#41COMPOSITIONS FOR REMODELING EXTRACELLULAR MATRIX AND METHODS OF USE THEREOF
#42METHODS AND COMPOSITIONS FOR CONSISTENT INTRACORONARY ADMINISTRATION OF A BIOLOGIC
#43Human Kynureninase enzymes and uses thereof
#44COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL ARTERY DISEASE
#45Epitope focusing by variable effective antigen surface concentration
#46RNA GUIDED COMPOSITIONS FOR PREVENTING AND TREATING HEPATITIS B VIRUS INFECTIONS
#47COMPOSITIONS AND METHODS FOR DECREASING INFLAMMATION
#48METHODS TO CONTROL LIPOKINE CONCENTRATIONS AND USES THEREOF
#49NEW LIPASE ENZYME
#50ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS
#51TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH
#52CNS DELIVERY OF THERAPEUTIC AGENTS
#53A chimeric endolysin polypeptide
#54COMPOSITIONS AND METHODS FOR THE TREATMENT OF SANFILIPPO DISEASE AND OTHER DISORDERS
#55COMPOSITION FOR INDUCING APOPTOSIS OF CELLS HAVING GENOMIC SEQUENCE VARIATION AND METHOD FOR INDUCING APOPTOSIS OF CELLS BY USING COMPOSITION
#56HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT FIBROSIS
#57Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof
#58LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
#59Methods and compositions for CNS delivery of iduronate-2-sulfatase
#60PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#61RNA-guided nucleic acid modifying enzymes and methods of use thereof
#62Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#63Use of Hsp70 as a regulator of enzymatic activity
#64METHODS AND COMPOSITIONS FOR THE EXPRESSION OF CONSTITUTIVELY ACTIVE RAP1A FROM A VMD2 PROMOTER
#65METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV
#66Compositions for remodeling extracellular matrix and methods of use thereof
#67METHODS OF TREATING LYSOSOMAL STORAGE DISEASES
#68Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
#69METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO ACID LEVEL
#70STABILIZING THERAPEUTIC PROTEINS WITH PIPERAZIN- OR MORPHOLINE-CONTAINING ZWITTERIONIC BUFFERING SUBSTANCES
#71METHODS FOR INDUCING FULL ABLATION OF HEMATOPOIESIS
#72Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
#73COMPOSITIONS AND METHODS FOR TREATING PEROXISOMAL BIOGENESIS DISORDERS
#74Oligosaccharide-protein conjugates
#75EXPRESSION VECTOR FOR CHOLESTEROL 24-HYDROLASE IN THERAPY OF RETT SYNDROME
#76DEVICES, COMPOSITIONS AND METHODS FOR COLONIC MICROBIOME ENGRAFTMENT
#77Yeast-fermented recombinant fibronectin peptide in small molecule, and its preparation method and applications thereof
#78PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES
#79Compositions and Methods for Treating Pathological Calcification and Ossification
#80METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#81TREATMENT OF SANFILIPPO SYNDROME TYPE B
#82Methods and compositions for CNS delivery of heparan N-sulfatase
#83Compositions for treating pathological calcification conditions, and methods using same
#84MESOPHILIC ARGONAUTE SYSTEMS AND USES THEREOF
#85METHODS OF TREATING NEURODEGENERATIVE DISEASES BY TARGETING THE PURINERGIC AND/OR ADENOSINE RECEPTORS
#86ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION
#87Methods and compositions for treatment of lysosomal storage disorders
#88DIAGNOSING AND TREATING ALZHEIMERS DISEASE
#89RECOMBINANT VECTORS FOR THE LONG TERM TREATMENT OF MUCCHOPOLYSACHARIDOSIS
#90APP MODIFICATION VIA BASE EDITING USING THE CRISPR/CAS9 SYSTEM
#91Method for improving intestinal flora
#92COMBINATION THERAPIES OF MICROORGANISMS AND IMMUNE MODULATORS FOR USE IN TREATING CANCER
#93NUCLEIC ACID CONSTRUCTS AND GENE THERAPY VECTORS FOR USE IN THE TREATMENT OF WILSON DISEASE
#94COMPOSITIONS FOR THE INHIBITION OF GIARDIA LAMBLIA
#95COMPOSITIONS FOR TREATING PATHOLOGICAL CALCIFICATION CONDITIONS, AND METHODS USING SAME
#96COMPOSITIONS AND METHODS FOR REDUCING CALCIFICATION OF HEART VALVES
#97MEANS AND METHODS FOR CLEAVAGE OF ZEARALENONE
#98COMPOSITIONS AND METHODS FOR TREATING WILSON'S DISEASE
#99NANOREACTOR USING POLYION COMPLEX POLYMERSOMES, AND METHOD FOR PRODUCING SAME
#100Acetylation of Miro1
#101COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISRODERS
#102Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
#103VECTORS AND METHODS OF USE
#104Oral care compositions
#105Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders
#106METHODS AND COMPOSITIONS FOR RESECTION MARGIN LAVAGE
#107Nucleic acids encoding kynurenine depleting enzymes
#108Human kynureninase enzyme variants having improved pharmacological properties
#109Gene sequence of recombinant human type II mitochondrial dynein-like GTPase and uses thereof
#110Compounds for improved viral transduction
#111Medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose, and a method for preparing thereof
#112Polypeptides for managing viral infections
#113BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#114Protein formulations and methods of making same
#115Protein formulations and methods of making same
#116Epitope focusing by variable effective antigen surface concentration
#117Treatment of infection by human enterovirus D68
#118Enzyme compositions and diagnostics for use in enterometabolic dysfunction
#119Compositions for remodeling extracellular matrix and methods of use thereof
#120BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#121Methods and compositions for CNS delivery of arylsulfatase A
#122Lysin polypeptides active against Gram-negative bacteria
#123Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
#124FRAGMENTS OF P97 AND USES THEREOF
#125Diagnosing and treating Alzheimer's disease
#126Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#127Compositions and methods for treating cancer using RHOA dominant negative forms
#128Compositions and methods for treating pathological calcification and ossification
#129Methods for treating pseudoxanthoma elasticum (PXE)
#130PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY
#131VECTORS AND METHODS OF USE
#132Oligosaccharide-protein conjugates
#133Oral care compositions
#134METHODS FOR INCREASING INTRACELLULAR ACTIVITY OF HSP70
#135Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
#136Methods of treating a subject with an alkaline phosphatase deficiency
#137Stable Bioactive Substances and Methods of Making
#138METHOD FOR MONOMERIZING MATRIX METALLOPROTEINASE 7 (MMP-7) AGGREGATE
#139Compositions for treating pathological calcification conditions, and methods using same
#140Use of Hsp70 as a regulator of enzymatic activity
#141CNS delivery of therapeutic agents
#142Use of HSP70 as a regulator of enzymatic activity
#143HUNTER SYNDROME THERAPEUTIC AGENT AND TREATMENT METHOD
#144Compositions and methods for treatment of uremic cardiomyopathy
#145Implantable medical product with permanently negatively charged surface
#146Probiotic compositions containing clostridiales for inhibiting inflammation
#147EGFR/MFN2 Targeted Nanoparticles Particularly Useful For Treating Multidrug Resistant Triple Negative Breast Cancer Through Mitochondrial Fusion Inhibition
#148Administration of kynurenine depleting enzymes for tumor therapy
#149Compounds for improved viral transduction
#150Methods and compositions for CNS delivery of iduronate-2-sulfatase
#151METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF DNASE1
#152Compositions and methods for treating retinopathy
#153TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68
#154THERAPEUTICALLY ACTIVE COMPLEXES
#155Methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
#156Epitope focusing by variable effective antigen surface concentration
#157PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#158Human kynureninase enzymes and uses thereof
#159Probiotic compositions containing clostridiales for inhibiting inflammation
#160Compositions for the inhibition of
#161Polypeptides for managing viral infections
#162RNA-guided nucleic acid modifying enzymes and methods of use thereof
#163TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral responses identified in a functional screen of an HSV-based cDNA library
#164Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#165METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA
#166COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#167TREATMENT OF INFLAMMATORY BOWEL DISEASE
#168Therapeutic acid ceramidase compositions and methods of making and using them
#169Compositions for treating pathological calcification conditions, and methods using same
#170Method for the treatment of lysosomal storage diseases
#171Methods for treating tracheobronchomalacia
#172Methods and compositions for CNS delivery of heparan n-sulfatase
#173Diagnosing and treating Alzheimer's disease
#174Feed additive composition
#175Compositions and methods for treating nonsteroidal anti-inflammatory drug (NSAID) associated coagulopathy, thrombocytopenia, glanzmann's thrombasthenia, and/or thrombosis
#176COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#177METHODS FOR IDENTIFYING AND TREATING HEMOGLOBINOPATHIES
#178METHODS AND MATERIALS FOR MODULATING DEUBIQUITINASES AND UBIQUITINATED POLYPEPTIDES
#179Intestinal flora improvement agent
#180Nanocapsule delivery system for ribonucleoproteins
#181Lysin polypeptides active against Gram-negative bacteria
#182Fragments of P97 and uses thereof
#183Compounds for improved viral transduction
#184Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
#185Methods for treating obesity
#186Methods of treating a subject with an alkaline phosphatase deficiency
#187Compositions and methods for treating pathological calcification and ossification
#188Methods of treating tissue calcification
#189Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders
#190Hunter syndrome therapeutic agent and treatment method
#191COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#192MODIFIED IDURONATE 2-SULFATASE AND PRODUCTION THEREOF
#193Diagnosing and treating Alzheimers disease
#194METHOD AND COMPOSITIONS FOR REMOVING DUPLICATED COPY NUMBER VARIAIONS (CNVS) FOR GENETIC DISORDERS AND RELATED USES
#195TARGETING MDA-5 ACTIVATION FOR CANCER IMMUNOTHERAPY
#196Medicine for treatment and/or prevention of ischemic diseases, method for improving angiogenesis-promoting activity of cells, or method for producing medicine
#197Epitope focusing by variable effective antigen surface concentration
#198BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#199METHODS OF TREATING LYSOSOMAL STORAGE DISEASES
#200Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase
#201Therapeutic acid ceramidase compositions and methods of making and using them
#202Products and Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders
#203Compositions and methods to inhibit viral replication
#204Use of Hsp70 as a regulator of enzymatic activity
#205Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#206Compositions and methods for treating platelet storage pool deficiency, gray platelet syndrome and quebec platelet disorder
#207PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSES HOST DISEASE
#208Nanoreactor using polyion complex polymersomes, and method for producing same
#209Compositions for remodeling extracellular matrix and methods of use thereof
#210Enzyme-treated milk product, preparation method thereof, composition, and products
#211Methods and compositions for segregating target nucleic acid from mixed nucleic acid samples
#212Methods and compositions for the treatment of lysosomal storage diseases
#213SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE
#214Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
#215Intranasal administration of guanidinylated aminoglycosides
#216Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
#217Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
#218Methods and compositions for CNS delivery of arylsulfatase A
#219Compositions for treating pathological calcification conditions, and methods using same
#220Compositions for treating pathological calcification conditions, and methods using same
#221Compositions for treating pathological calcification conditions, methods, and host cells using the same
#222AAV-mediated gene therapy for RPGR X-linked retinal degeneration
#223METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#224PROBIOTIC COMPOSITIONS CONTAINING CLOSTRIDIALES FOR INHIBITING INFLAMMATION
#225Method for treating Huntingtons's disease
#226Modulation and detection of a neuronal alternative splicing regulatory network for treatment and diagnosis of neurological disorders
#227EXTRACELLULAR VESICLES WITH ENHANCED POTENCY
#228COMPOSITIONS FOR INCREASING SURVIVAL OF MOTOR NEURON PROTEIN (SMN) LEVELS IN TARGET CELLS AND METHODS OF USE THEREOF FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
#229Compositions and methods for treating pathological calcification and ossification
#230Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson disease
#231Compositions for treating pathological calcification conditions, and methods using same
#232Compositions for treating pathological calcification conditions, and methods using same
#233Compositions and Methods for Treating Pathological Calcification and Ossification
#234ADP'ASE-ENHANCED APYRASE THERAPY FOR WOUNDS, MICROBIAL INFECTION, SEPSIS, AND HETEROTOPIC OSSIFICATION
#235Modulators of ACYL-COA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
#236Uses of FAHD1
#237Methods and compositions for consistent intracoronary administration of a biologic
#238Compositions and methods for treating thyroid disease
#239Treatment of infection by human enterovirus D68
#240TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral responses identified in a functional screen of an HSV-based cDNA library
#241Compositions and methods for treating hemophilia
#242Methods for increasing intracellular activity of Hsp70
#243Compositions and methods for treating pathological calcification and ossification
#244Oligopeptidic compounds and uses thereof
#245Compositions for the inhibition of
#246Compositions and methods for regulating glucose metabolism
#247Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#248Cardiotonic steroid antagonists and related methods
#249Method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregate
#250SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE
#251PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS
#252ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY
#253CNS delivery of therapeutic agents
#254METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE
#255Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
#256Methods and compositions for treating nephrogenic diabetes insipidus
#257Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
#258Pharmaceutical composition with improved stability containing factor VII fusion protein
#259FRAGILE HISTIDINE TRIAD (FHIT) COMPOSITIONS AND USES THEREOF
#260Fragments of P97 and uses thereof
#261Diagnosing and treating alzheimer's disease
#262Methods and compositions for segregating target nucleic acid from mixed nucleic acid samples
#263Use of Hsp70 as a regulator of enzymatic activity
#264PROTEINS FOR TARGETING NEURONAL NITRIC OXIDE SYNTHASE TO MUSCLE SARCOLEMMA AND RELATED METHODS OF USE
#265Feed additive composition
#266Polypeptide targeting to mitochondria
#267Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
#268Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
#269PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS
#270Probiotic compositions containing clostridiales for inhibiting inflammation
#271Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
#272Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides
#273Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses
#274Administration of kynurenine depleting enzymes for tumor therapy
#275Therapeutic acid ceramidase compositions and methods of making and using them
#276Compositions and Methods for Treatment of Stroke
#277Intranasal administration of guanidinylated aminoglycosides
#278Compositions and methods for treating pathological calcification and ossification
#279Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
#280PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS
#281TRPV1 modulatory gene product that affects TRPV1-specific pain behavioral responses identified in a functional screen of an HSV-based cDNA library
#282Bacteriophage lysin and antibiotic combinations against gram positive bacteria
#283Clinical Applications for Recombinant Human MxA Protein
#284APYRASE TREATMENTS
#285APYRASE THERAPY FOR FIBROPROLIFERATIVE DISORDERS, PULMONARY HYPERTENSION, AND HEART FAILURE
#286Compositions and methods for promoting intestinal stem cell function
#287HSP104 variants and uses thereof
#288Attenuating or treating sepsis or septic shock
#289AAV-mediated gene therapy for RPGR X-linked retinal degeneration
#290Combination for treating an inflammatory disorder
#291Thermostable phytase variants
#292Mycotoxin-reducing composition
#293Methods of treatment of cancer using SRC-modulating peptides
#294Methods of Inhibiting Cell Proliferation
#295Polypeptide mixes with antibacterial activity
#296Epitope focusing by variable effective antigen surface concentration
#297Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
#298MIXTURE OF ENZYMES FROM ANTARCTIC KRILL FOR USE IN THE REMOVAL OF A BIOFILM
#299Subcutaneous administration of iduronate-2-sulfatase
#300Administration of kynurenine depleting enzymes for tumor therapy